What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Hyperthermia Devices Market Size, Share, Growth, and Global Industry Analysis by Type (Microwave Hyperthermia Devices & Ultrasound Hyperthermia Devices), By Application (Hospitals, Clinics & Others), Regional Insights and Forecast From 2025 To 2034
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
HYPERTHERMIA DEVICES MARKET OVERVIEW
The global Hyperthermia Devices Market is poised for significant growth USD 5.42 billion in 2025, and projected to reach USD 8.15 billion by 2034, with a CAGR of 5.22% from 2025 to 2034.
The United States Hyperthermia Devices market is forecasted to reach USD 1.88 billion in 2025, the Europe market at USD 1.60 billion, and the China market at USD 1.14 billion.
Solid tumors are treated using hyperthermia equipment’s. In order to increase the therapeutic effectiveness of current radio- and/or chemotherapies, hyperthermia is typically used as an adjunctive treatment. This method of treatment involves heating human tissues to a high temperature (113°F) in order to kill and destroy cancer cells while preserving healthy tissues. Thermal therapy, thermal ablation, or thermotherapy are various names for hyperthermia used to treat cancer. Doctors use different types of technique to create the heat which is required to kill the cancer tissues, the types include using microwave to create energy, radio waves which is also called as radio frequency, lasers, ultrasound & others.
Hyperthermia gadget that treats cancer is not widely available. However, at some centers it is used, along with other treatments such as radiation therapy and chemotherapy, for advanced cancers. It has been used to treat appendix cancer, bladder, brain cancer, breast, cervical cancer, esophageal cancer, head and neck cancer & others. According to the American Cancer Society, a different hyperthermia method can be utilized in conjunction with surgery to treat abdominal tumors (the space in the body that contains the intestines and other digestive organs). Chemotherapy medications are heated and pumped through the peritoneal cavity during surgery. Continuous hyperthermic abdominal circulation, also referred to as hyperthermic intraperitoneal chemotherapy, is what is happening here. This has shown promise in tests for treating some cancer types, but it is not yet clear whether it is superior to other forms of therapy.
KEY FINDINGS
- Market Size and Growth: The global hyperthermia devices market is projected to reach USD 5.42 billion in 2025 and USD 8.15 billion by 2034.
- Key Market Driver: The usage of external and interstitial hyperthermia devices in treating deep-seated cancers grew by 19.6% globally in 2023.
- Major Market Restraint: Hyperthermia equipment shortage caused a 13.4% decline in device availability across oncology centers during the COVID-19 pandemic.
- Emerging Trends: Over 21.3% of new oncology centers are adopting image-guided thermometry probes, increasing procedural accuracy in hyperthermia treatment.
- Regional Leadership: North America accounts for approximately 34.7% of the global hyperthermia devices market due to import volume and device development initiatives.
- Competitive Landscape: Pyrexar Medical, Celsius42, and Oncotherm together hold 48.5% of the global hospital and clinic device supply share as of 2023.
- Market Segmentation: Ultrasound devices hold 55.2%, while microwave-based devices account for 44.8%; hospitals dominate application usage at 66.1%, followed by clinics at 23.7%.
- Recent Development: In 2023, Celsius42 launched a dual-frequency modulation feature, improving temperature control accuracy by 27.5% in deep-tissue hyperthermia sessions.
COVID-19 Impact: Downfall of Sales Leads to Market Distortion
The global COVID-19 pandemic has been unprecedented and staggering, with hyperthermia devices experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The rise in CAGR is attributable to the hyperthermia devices market growth and demand returning to pre-pandemic levels once the pandemic is over.
There is no doubt that the COVID-19 pandemic had presented a challenge for consumer goods companies in some way, causing market instability, declining customer confidence, and disruptions in import and export activity. The COVID-19 outbreak hit the hyperthermia market leaving a trail of destruction in its awake. Numerous of these modifications are having an extended impact. As they adjust to these new realities, businesses in every sector—including the medical industry—adopt new technology and methods of operation. The medical industry had experienced a shortage of devices, including hyperthermia equipment, due to a lack of supplies and emergency situations. The hyperthermia devices market experienced a decline in their supply chain since patient rates were high and human touch was not permitted. But as things stabilized, the hyperthermia market also did.
LATEST TRENDS
Unique Hyperthermia Devices Treatment Improves Market Flow
Almost always, hyperthermia is combined with other cancer therapies. Numerous clinical studies have demonstrated that using hyperthermia in conjunction with therapies like radiation therapy and chemotherapy can help reduce tumors and may facilitate the killing of cancer cells. A local an aesthetic is applied to the treatment area before the doctor inserts microscopic probes equipped with thermometers into the tumor. During therapy, thermometers enable the clinician to keep a careful eye on the temperature of the tumor and surrounding tissue. Using imaging methods like CT scans, it may be possible to verify that the probes are positioned correctly. This unique way of treating illnesses is helping the market to grow.
- According to the American Cancer Society, hyperthermia is increasingly used as an adjunct treatment with radiation and chemotherapy, improving tumor control by 26% in certain soft tissue sarcoma cases.
- Based on data published by the National Cancer Institute (NCI), advanced image-guided hyperthermia therapies have shown a 21.4% improvement in local tumor response rate for patients with cervical and bladder cancers between 2021 and 2023.
HYPERTHERMIA DEVICES MARKET SEGMENTATION
-
By Types
Based on type, the market is classified into Microwave Hyperthermia Devices & Ultrasound Hyperthermia Devices.
-
By Application
Based on application, the market is categorized into Hospitals, Clinics & Others.
DRIVING FACTORS
Different Forms of Hyperthermia Treatments to Accelerate Market Growth
Different kinds of hyperthermia tools, from little to big areas, are used throughout the body. Local hyperthermia, external hyperthermia, interstitial hyperthermia, and others are the various forms of hyperthermia. The hyperthermia gadget is used by doctors in limited, low-heat areas. Tumors on or near the skin can be treated with external hyperthermia. Doctors set up heating equipment in or around the treatment area for this kind of hyperthermia. Deep-lying cancers in the body, such those in the brain, are treated with interstitial hyperthermia. With this kind of hyperthermia, the tumor can be heated to higher degrees than with exterior methods. This improves overall hyperthermia devices market growth.
- As per the World Health Organization (WHO) cancer statistics, over 10 million deaths in 2022 were cancer-related, increasing the demand for alternative therapies like hyperthermia, especially in regions with limited access to surgery.
- Data from the European Society for Hyperthermic Oncology confirms that the integration of radiofrequency and microwave-based hyperthermia systems in hospitals has grown by 31.6% from 2020 to 2023, driven by their effectiveness in deep-seated tumor management.
Continues Development of the Product Leading to Increase Market Sales
Although hyperthermia is a promising method for enhancing cancer treatment, it is now primarily an experimental approach. With numerous equipment and doctor's, the experimentation on devices increases which will result in nee technique that will cure the other cancer issues. For the purpose of understanding and perfecting this method, numerous clinical trials of hyperthermia are being conducted. Researchers are still investigating the best ways to combine heat with other cancer treatments for better results. Additionally, research is exploring on techniques to access deeper organs and other areas that, as of now, cannot be treated with hyperthermia. With the development of new treatment, the hyperthermia devices market will reach a new height.
RESTRAINING FACTORS
Shortage of Equipment to Hinder the Market Growth
Hyperthermia therapy is a rare form of treatment that needs specialized tools and knowledge. Additionally, it is unclear whether it makes people live longer. According to National Cancer Institute not most healthy tissues is damaged during hyperthermia, but varied characteristics of certain tissues could lead to higher temperatures in specific areas. Burns, blisters, discomfort, or pain may result from this. Swelling, blood clots, bleeding, and other damage to the normal tissues can be caused by perfusion techniques. But most of these side effects improve after treatment. Recent developments in hyperthermia devices market will really help to grow the number.
- According to the U.S. Food & Drug Administration (FDA), fewer than 16% of medical institutions in the U.S. are currently equipped with licensed hyperthermia treatment systems, limiting access for broader patient populations.
- As reported by the National Comprehensive Cancer Network (NCCN), over 22.5% of oncologists cite lack of insurance reimbursement for hyperthermia therapy as a critical barrier, reducing its use in standard oncology practices.
-
Request a Free sample to learn more about this report
HYPERTHERMIA DEVICES MARKET REGIONAL INSIGHTS
Leading Exporters & Importers Driving Market Growth
North America is the leading exporter & importer of the hyperthermia devices market share. Controlling the table, the U.S. produces a high-quality devices and imports nearly various shipments, which are purchased by many companies and hospital facilities. The advancement in hyperthermia gadget has helped the market as a whole, it is growing quickly and will continue to do so in the years to come.
KEY INDUSTRY PLAYERS
Leading Firms to Increase Product Demand
The study includes information on the market players and where they stand within the sector. Through appropriate research, mergers, technological development, expanding production facilities, and collaboration, data is being acquired and made available. The study on devices offers details on manufacturers, regions, types, applications, sales channels, distributors, traders, dealers, research findings, and more.
- Pyrexar Medical (U.S.): As per internal U.S. FDA device registration data, Pyrexar Medical accounts for approximately 38% of all registered clinical hyperthermia systems sold in North America as of 2023.
- Celsius42 (Germany): According to figures from the German Federal Institute for Drugs and Medical Devices (BfArM), Celsius42 has installed over 190 active systems in oncology clinics across Europe, with a 19.8% increase in unit deployment between 2021 and 2023.
List Of Top Hyperthermia Devices Companies
- Pyrexar Medical (U.S.)
- Oncotherm (Hungary)
- Celsius42 (Germany)
- Andromedic (Italy)
- Pearson (U.K.)
- Nanjing Greathope (China)
- Shanghai Huayuan (China)
REPORT COVERAGE
Every facet of the market is investigated in the study, including market segmentation by type and application. A wide range of participants, including present and potential market leaders, are examined in the study. Significant market expansion is anticipated to be fueled by several important factors. The research also includes factors that are probably to increase hyperthermia market share in order to provide market insights. Additionally, market growth forecasts for the anticipated term are included in the research. Explaining why one region dominates the global market is the aim of the regional study. A number of problems, all of which are carefully evaluated, prevent the market from expanding. The study also includes a market strategic analysis. It includes thorough market information.
Attributes | Details |
---|---|
Market Size Value In |
US$ 5.42 Billion in 2025 |
Market Size Value By |
US$ 8.15 Billion by 2034 |
Growth Rate |
CAGR of 5.22% from 2025 to 2034 |
Forecast Period |
2025-2034 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Types
|
|
By Application
|
FAQs
The Hyperthermia Devices Market is expected to reach USD 8.15 billion by 2034.
The Hyperthermia Devices Market is expected to exhibit a CAGR of 5.22% by 2034.
Different forms of hyperthermia treatments that accelerate market growth & continues development of the product leading to increase market sales were the two-driving factor of the hyperthermia devices market.
Shortage of Equipment & High Temperature Damage Which Will Cause Body Issues.
The global hyperthermia devices market is projected to reach USD 5.42 billion in 2025.
North America holds 34.7% market share, followed by Europe and China with strong demand from oncology centers.
The primary types include microwave hyperthermia devices and ultrasound hyperthermia devices.
Key players include Pyrexar Medical (U.S.), Celsius42 (Germany), and Oncotherm (Hungary), holding a combined 48.5% market share.